HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,729,000 | -78.3% | 1,400,000 | -87.0% | 0.00% | -100.0% |
| Q1 2020 | $12,560,000 | -33.6% | 10,785,000 | -24.2% | 0.00% | 0.0% |
| Q4 2019 | $18,920,000 | +29.5% | 14,225,000 | +13.3% | 0.00% | 0.0% |
| Q3 2019 | $14,605,000 | +7.0% | 12,550,000 | +2.4% | 0.00% | 0.0% |
| Q2 2019 | $13,653,000 | +3.3% | 12,250,000 | +5.2% | 0.00% | 0.0% |
| Q1 2019 | $13,215,000 | +8.3% | 11,650,000 | -4.5% | 0.00% | 0.0% |
| Q4 2018 | $12,198,000 | -4.0% | 12,200,000 | -3.4% | 0.00% | 0.0% |
| Q3 2018 | $12,705,000 | +4.2% | 12,625,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $12,189,000 | +5.1% | 12,625,000 | +0.4% | 0.00% | 0.0% |
| Q1 2018 | $11,595,000 | +0.9% | 12,575,000 | +2.4% | 0.00% | 0.0% |
| Q4 2017 | $11,488,000 | +97.7% | 12,275,000 | +91.1% | 0.00% | 0.0% |
| Q3 2017 | $5,812,000 | – | 6,425,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 136,032,000 | $150,514,000 | 5.41% |
| SYMPHONY ASSET MANAGEMENT LLC | 16,000,000 | $17,780,000 | 3.72% |
| CSS LLC/IL | 12,427,000 | $13,791,000 | 0.79% |
| SSI INVESTMENT MANAGEMENT LLC | 8,793,000 | $9,740,000 | 0.72% |
| Worth Venture Partners, LLC | 1,103,000 | $1,227,000 | 0.68% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,900,000 | $33,208,000 | 0.64% |
| Sonora Investment Management, LLC | 4,840,000 | $5,374,000 | 0.60% |
| Empyrean Capital Partners, LP | 8,000,000 | $8,875,000 | 0.40% |
| DLD Asset Management, LP | 5,500,000 | $6,129,000 | 0.26% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 12,500 | $10,496,000 | 0.25% |